WHO Global Benchmarking Tool + Blood (GBT + blood) for evaluation of national regulatory systems of blood products including whole blood, blood components and plasma derived products
Global Benchmarking Tool (GBT) Revision VI+ version 1 published in November 2019 is the latest release of GBT + blood for benchmarking of blood products national regulatory systems. This release comprises ten (10) regulatory functions (listed below) under the overarching framework of the national regulatory system (RS).
All queries related to GBT + blood including requests for the computerized platform (cGBT) should be sent to the WHO Regulatory Systems Strengthening Team at nra_admin@who.int.
Fact sheets on GBT components
Links to fact sheets on the above listed components of the GBT + blood, and a glossary of key terms, are available below.
1 November 2019
WHO global benchmarking tool plus rev. VI+ ver. 1 - National Regulatory System (RS)
1 November 2019
WHO global benchmarking tool plus rev. VI+ ver. 1 - Registration and Marketing Authorization (MA)
1 November 2019
WHO global benchmarking tool plus rev. VI+ ver. 1 - Vigilance (VL)
1 November 2019
WHO global benchmarking tool plus rev. VI+ ver. 1 - Market Surveillance and Control (MC)
1 November 2019
WHO global benchmarking tool plus rev. VI+ ver. 1, Licensing Establishments (LI)
1 November 2019
WHO global benchmarking tool plus rev. VI+ ver. 1 - Regulatory Inspection (RI)
1 November 2019
WHO global benchmarking tool plus rev. VI+ ver. 1 - Laboratory Testing (LT)
1 November 2019
WHO global benchmarking tool plus rev. VI+ ver. 1 - Clinical Trials Oversight (CT)
1 November 2019
WHO global benchmarking tool plus rev. VI+ ver. 1 - NRA Lot Release (LR)
1 November 2019
WHO global benchmarking tool plus rev. VI+ ver. 1. Approval of blood and blood components, including plasma for fractionation (product and/or process approval) (AB)
1 November 2019